UNICREDIT BANK/CALL/ABBVIE/210/0.1/18.12.24 Stock

Warrant

DE000HC8N3S8

Market Closed - BOERSE MUENCHEN 15:41:34 2024-05-28 EDT
0.043 EUR +48.28% Intraday chart for UNICREDIT BANK/CALL/ABBVIE/210/0.1/18.12.24
Current month-73.64%
1 month-73.64%
Date Price Change
24-05-28 0.043 +48.28%
24-05-27 0.029 -51.67%
24-05-24 0.06 +9.09%
24-05-23 0.055 -12.70%
24-05-22 0.063 -16.00%

Real-time BOERSE MUENCHEN

Last update May 28, 2024 at 03:41 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBVIE INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HC8N3S
ISINDE000HC8N3S8
Date issued 2023-08-14
Strike 210 $
Maturity 2024-12-18 (204 Days)
Parity 10 : 1
Emission price 0.3
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.49
Lowest since issue 0.008

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
155.3 USD
Average target price
182.3 USD
Spread / Average Target
+17.33%
Consensus